Sanofi Consumer Healthcare India Limited has made the video recording of its institutional investor meet available on the company website, following the successful SCHIL Institutional Investor Meet held on March 24, 2026, in Mumbai. The company has communicated this development to stock exchanges under SEBI Listing Regulations.

Video Recording Availability

The company has informed BSE Limited and National Stock Exchange of India Limited about the availability of the video recording pursuant to Regulation 30 of SEBI Listing Regulations. Company Secretary and Compliance Officer Nikunj Kumar Savaliya (Membership No.: F7048) signed the formal communication on March 26, 2026.

Meeting Execution and Presentation

The institutional investors meet was successfully conducted as a physical group interaction in Mumbai, as previously announced on March 19, 2026. The company shared a comprehensive presentation showcasing its business transformation journey, strategic roadmap, and performance metrics.

Business Performance Highlights

The presentation revealed strong financial performance with significant growth across key metrics. The company demonstrated robust operational improvements following its demerger and transformation into a focused consumer healthcare entity.

Strategic Focus Areas

The presentation outlined the company's three-pillar strategy focusing on scaling HCP initiation, consumer engagement, and improving access. The company highlighted significant market opportunities in its core categories of pain, allergy, and vitamin D segments.

Sanofi Consumer Healthcare India Limited has published its postal ballot notice in newspapers on March 24, 2026, confirming the successful dispatch to shareholders seeking approval for material related party transactions and key remuneration matters. The company filed the publication notice with BSE Limited and National Stock Exchange of India Limited, completing regulatory compliance requirements.

Postal Ballot Publication Details

The company published the postal ballot notice in two newspapers to ensure widespread shareholder awareness:

Shareholder Approval Resolutions

The postal ballot seeks shareholder approval for four ordinary resolutions covering significant corporate matters:

Related Party Transaction Approvals

The company is seeking approval for significant related party transactions with two group entities during the financial year ending December 31, 2026:

Voting Process and Timeline

The postal ballot follows a comprehensive electronic voting process managed by National Securities Depository Limited (NSDL):

Scrutinizer Appointment

The Board of Directors has appointed qualified scrutinizers to ensure fair and transparent voting:

Remuneration Matters

The postal ballot includes important remuneration decisions affecting company leadership:

Non-Executive Director Commission

Shareholders will vote on extending authorization for paying commission to Non-Executive Directors for five years from January 1, 2025 to December 31, 2029, maintaining the current structure of maximum 1% of net profits plus sitting fees.

Managing Director Incentive Plan

The company seeks approval for Mr. Himanshu Bakshi's participation in the Global Long Term Incentive Plan, enhancing the existing compensation framework to align with international best practices.

Regulatory Compliance

All proposed transactions comply with SEBI Listing Regulations and have received prior Audit Committee approval. The transactions are structured to be conducted at arm's length basis and in the ordinary course of business. Related parties will abstain from voting on respective resolutions as per regulatory requirements.

Shareholders can access detailed information on the company's website at www.sanofi.in and NSDL's e-voting portal for comprehensive voting procedures and resolution details.

Source: None/Company/INE0UOS01011/3503441a-9928-48be-aba6-77161e590388.pdf